Home/Filings/4/0001209191-13-001321
4//SEC Filing

LEWIS JONATHAN 4

Accession 0001209191-13-001321

CIK 0001107421other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:16 PM ET

Size

8.7 KB

Accession

0001209191-13-001321

Insider Transaction Report

Form 4
Period: 2012-12-31
LEWIS JONATHAN
DirectorCEO
Transactions
  • Tax Payment

    Common Stock

    2012-12-31$4.21/sh14,715$61,950546,251 total
  • Award

    Employee Stock Option (right to buy)

    2012-12-31+300,000300,000 total
    Exercise: $4.16Exp: 2022-12-31Common Stock (300,000 underlying)
  • Tax Payment

    Common Stock

    2012-12-31$4.16/sh21,475$89,336524,776 total
Footnotes (2)
  • [F1]Disposition represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant.
  • [F2]100,000 shares vest on 12/31/2013; and 100,000 shares vest on each of 12/31/2014 and 12/31/2015.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001338532

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:16 PM ET
Size
8.7 KB